LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 93.96 | 27.76 | 8807 | 6849 | 1.2859 | 1.0643 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 95.66 | 27.76 | 5468 | 6712 | 0.8146 | 0.9489 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 95.66 | 27.76 | 13294 | 6712 | 1.9804 | 1.1803 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 95.66 | 27.76 | 1 | 6712 | 0.0001 | -0.3428 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 95.66 | 27.76 | 8653 | 6712 | 1.2891 | 1.0652 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 1.95 | 27.76 | 440 | 225 | 1.9543 | 1.4968 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 1.95 | 27.76 | 122 | 225 | 0.5419 | 0.6327 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 3.66 | 27.76 | 574 | 283 | 2.0216 | 1.4670 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 3.66 | 27.76 | 276 | 283 | 0.9721 | 0.9832 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 5.36 | 27.76 | 647 | 320 | 2.0196 | 1.4409 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 5.36 | 27.76 | 427 | 320 | 1.3329 | 1.1697 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.06 | 27.76 | 701 | 360 | 1.9472 | 1.3950 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.06 | 27.76 | 542 | 360 | 1.5056 | 1.2341 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 8.76 | 27.76 | 2 | 401 | 0.0050 | -0.4947 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 8.76 | 27.76 | 794 | 401 | 1.9793 | 1.3877 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 8.76 | 27.76 | 606 | 401 | 1.5107 | 1.2260 | MN20160318_Q01 | D12 |